Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer
Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer
Active, not recruiting · NCT02862275 · Registry updated 2026-06-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer | Hemic and Lymphatic Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, hematopoietic and lymphoid cell neoplasm, hematopoietic and lymphoid system neoplasm, neoplasm | Active, not recruiting | Phase 1 | 2026-06-17 | NCT02862275 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Emory Saint Joseph's Hospital | Atlanta | United States | 175 |
| Emory University Hospital Midtown | Atlanta | United States | 246 |
| Emory University Hospital/Winship Cancer Institute | Atlanta | United States | 299 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| Moffitt Cancer Center-International Plaza | Tampa | United States | 67 |
| Ohio State University Comprehensive Cancer Center | Columbus | United States | 548 |
| UC San Diego Moores Cancer Center | La Jolla | United States | 199 |
| University Health Network-Princess Margaret Hospital | Toronto | Canada | 88 |
| UT MD Anderson Cancer Center | Houston | United States | 204 |